- Ciències Mèdiques Bàsiques
Departamento
![Foto de - Ciències Mèdiques Bàsiques](/img/noimage.png)
![Foto de Institució Catalana de Recerca i Estudis Avançats](/img/noimage_org.png)
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (32)
2024
-
Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease
Human Pathology, Vol. 143, pp. 50-61
-
MicroRNA-centered theranostics for pulmoprotection in critical COVID-19
Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1
2023
-
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research, Vol. 24, Núm. 1
-
Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Changing biosynthesis of terpenoid percursors in rice through synthetic biology
Frontiers in Plant Science, Vol. 14
-
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
Molecular Cancer, Vol. 22, Núm. 1
-
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs
International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165
-
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Gut, Vol. 73, Núm. 3, pp. 496-508
2022
-
Multilevel interactions between native and ectopic isoprenoid pathways affect global metabolism in rice
Transgenic Research, Vol. 31, Núm. 2, pp. 249-268
-
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
Clinical Cancer Research, Vol. 28, Núm. 16, pp. 3443-3451
2021
-
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
Gastroenterology, Vol. 161, Núm. 3, pp. 879-898
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Copy-number alteration burden differentially impacts immune profiles and molecular features of hepatocellular carcinoma
Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6350-6361
-
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Journal of Hepatology, Vol. 73, Núm. 2, pp. 315-327
-
SIVA-1 regulates apoptosis and synaptic function by modulating XIAP interaction with the death receptor antagonist FAIM-L
Cell Death and Disease, Vol. 11, Núm. 2
2019
-
Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors
Nature Communications, Vol. 10, Núm. 1
-
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
British Journal of Cancer, Vol. 121, Núm. 4, pp. 340-343
-
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Gut, Vol. 68, Núm. 6, pp. 1065-1075
-
New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma
Clinical Liver Disease, Vol. 14, Núm. 2, pp. 56-61
-
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Journal of Hepatology, Vol. 70, Núm. 6, pp. 1262-1277